Join us for an informative overview of COVID-era issues associated with antimicrobial claims and recent EPA rules concerning “long-lasting” claims for residual efficacy of antimicrobial.
Presented by: Shumaker Partner Joe Simpson
July 20th / Noon to 1:00 p.m. EDT
- U.S. EPA’s new protocol for residual efficacy claims for antimicrobials.
- Enhanced enforcement by U.S. EPA and FDA concerning disinfectants and hand sanitizers.
- Expedited review of products intended to combat COVID-19.